MIT researchers have engineered ligand-directed lipid nanoparticles that reprogram natural killer cells into CAR-bearing ...
In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem cells to generate a continuous supply of functional T cells, the immune ...
Scientists at UC San Francisco have developed a way to create cancer-fighting CAR-T cells directly inside the body, potentially avoiding the slow and extremely expensive process of removing, ...
In a study published in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of Medical Research ...
SAN CARLOS, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the ...
Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics for solid tumors, announced the close of its seed financing round, bringing the company’s total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results